Cadila receives 3 observations from USFDA for its Baddi formulation plant
Cadila Healthcare said that it has received three observations from USFDA for its formulation facility at Baddi, Himachal Pradesh. From February 20 to March 1,...
Tag : USFDA
Panacea Biotec has got EIR from USFDA for Baddi facilities
The Establishment Inspection Report (EIR) has been received by the drug firm Panacea Biotec from the US health regulator after successful inspection of its manufacturing...
Alembic Pharma has received EIR report from USFDA
Alembic Pharmaceuticals has got the Establishment Inspection Report from the USFDA for its formulation facility located at Panelav in Gujarat. Alembic Pharmaceuticals has said in...
Cadila Healthcare has received EIR for Ahmedabad plant from USFDA
Cadila Healthcare has received an Establishment Inspection Report (EIR) from the US health regulator for its manufacturing plant in Ahmedabad. Cadila Healthcare Ltd has said...
USFDA has issued warning letter to Unimark Remedies
The US Food and Drug Administration (USFDA) has warned Unimark Remedies on violation of good manufacturing practices at its two plants in Gujarat. It added...
Cadila has received EIR from USFDA for Changodar facility
Cadila Healthcare has got the Establishment Inspection Report (EIR) for its Changodar manufacturing plant that is located near Ahmedabad, from the US health regulator after...
Alembic Pharma has received tentative approval from USFDA for Febuxostat
The US health regulator has provided its tentative approval to Alembic Pharmaceuticals for Febuxostat tablets that are used in the treatment of hyperuricemia in patients...
EIC, USFDA signs agreement to share information on import alerts
An agreement has been signed by the Export Inspection Council of India and the US health regulator for facilitating the sharing of information relating to...
Strides Shasun has received EIR report from USFDA
An Establishment Inspection Report (EIR) has been received by the drug firm Strides Shasun from the US health regulator on closure of inspection of its...
Strides receives tentative approval from USFDA for Roflumilast tablets
The US health regulator has given its tentative approval to Strides Shasun for Roflumilast tablets that are used in the treatment of inflammatory conditions of...